CDK4 and breast carcinoma: Our results demonstrate that low Pxn phosphorylation levels at Ser 83, consequent to the reduced CD1/Cdk4 functional interaction, led to inhibition of Rac1-activity, as evidenced by the decrease of pSer144-Pak1 levels, in all breast cancer cell lines tested.